Negative Conversion of Polymerase Chain Reaction and Clinical Outcomes according to the SARS-CoV-2 Variant in Critically Ill Patients with COVID-19

Tae-Hun KIM; Eunjeong JI; Myung-Jin SONG; Sung-Yoon LIM; Yeon-Joo LEE; Young-Jae CHO.
Tuberculosis and Respiratory Diseases ; : 142-149, 2023.
Artículo en Inglés | WPRIM | ID: wpr-968830

Documentos relacionados

  1. Negative Conversion of Polymerase Chain Reaction and Clinical Outcomes according to the SARS-CoV-2 Variant in Critically Ill Patients with COVID-19.
  2. Clinical and Virological Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta) Variant: A Prospective Cohort Study.
  3. Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19.
  4. Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19.
  5. Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020-2022.
  6. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
  7. Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization.
  8. Impact of Vaccination, Prior Infection, and Therapy on Omicron Infection and Mortality.
  9. Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.
  10. Impact of Vaccination and the Omicron Variant on COVID-19-related Chest CT Findings: A Multicenter Study.